Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis - Press Release
FDA greenlights Alentis Phase 1 protocol study design Alentis to begin transition from pre-clinical to clinical Alentis Therapeutics, AG today announc
United States Rd Roberto Iacone French National Institute Of Health Inserm University Of Strasbourg Alentis Phase Alentis Therapeutics
Source: wiredprnews.com